Correction: NIH is fully funding Sanyal's ASH trial as well as Vos's pediatric NASH trial. Immuron had to fund the March 2018 Phase II NASH trial readout. But still.
Immuron and it's platform has support from U.S. Department of Defense (Army/Navy), NIH, Arun Sanyal, Passport Health, Maryland Medicine Center for Vaccine Development, Dr. Tacket (who wrote the groundbreaking work on ETEC HBC), New England Journal of Medicine, Dr. Rogler (world-renowned colitis expert), Dr. Vos (world renowned pediatric NASH expert), and now Gary Jacobs CEO, who developed Trulance basically singlehandedly.
What other $25M USD market cap company (other than arguably ENDRA Life Sciences...partner GE Healthcare....precursor tech used at Stanford, Michigan, etc.) has this type of impressive support?
- Forums
- ASX - By Stock
- Carol Tacket, Travelan, and the New England Journal of Medicine
Correction: NIH is fully funding Sanyal's ASH trial as well as...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.93M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.5¢ | $1.158K | 11.03K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 9352 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 251204 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 9352 | 0.105 |
5 | 347605 | 0.100 |
1 | 52520 | 0.095 |
1 | 9695 | 0.092 |
2 | 145000 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 111204 | 3 |
0.115 | 100000 | 2 |
0.120 | 193000 | 3 |
0.130 | 218736 | 6 |
0.140 | 105750 | 2 |
Last trade - 10.48am 27/08/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online